Griffiths E A, Brummell Z, Gorthi G, Pritchard S A, Welch I M
Department of Gastrointestinal Surgery, South Manchester University Hospital NHS Trust, South Moor Road, Wythenshawe, Manchester M23 9LT, UK.
Eur J Surg Oncol. 2006 May;32(4):413-9. doi: 10.1016/j.ejso.2005.11.024. Epub 2006 Feb 28.
Our aim was to assess the effect on survival of circumferential resection margin (CRM) involvement in patients with resected oesophageal malignancy.
Patients undergoing potentially curative oesophageal resection between January 1994 and December 2003 were retrospectively analysed. CRM status was defined as either clear or involved (microscopic tumour within 1 mm of the inked resection margin). Univariate and multivariate survival analyses were performed using the Kaplan-Meier method and Cox proportional hazard model. Overall survival was used as the endpoint.
The case records of 249 patients were analysed. CRM status was clear in 170 patients (T1-T3 tumours) and involved in 79 patients (all T3 tumours). Median survival in these groups was 37 months (range 28-47) and 18 months (range 13-23), respectively (p = 0.0001). When T3 tumours were analysed separately there was a trend for T3 CRM involved tumours to have a worse prognosis than T3 CRM clear tumours (p = 0.074). Substratification by percentage of lymph nodes involved by metastases (< or = or >25%) revealed that CRM status had a greater prognostic effect in T3 tumours with a low metastatic lymph node burden (p = 0.04).
CRM involvement predicts poor prognosis in patients with resected oesophageal malignancy and was an independent prognostic factor in our study. There was only a trend for worse prognosis when T3 tumours were analysed separately. However, patients with T3 tumours and a low percentage of lymph node metastases had a better prognosis if the CRM was negative.
我们的目的是评估环周切缘(CRM)受累对接受手术切除的食管恶性肿瘤患者生存的影响。
对1994年1月至2003年12月间接受潜在根治性食管切除术的患者进行回顾性分析。CRM状态定义为切缘阴性或受累(距标记的切缘1毫米内有微小肿瘤)。采用Kaplan-Meier法和Cox比例风险模型进行单因素和多因素生存分析。总生存作为终点指标。
分析了249例患者的病例记录。170例患者(T1-T3肿瘤)的CRM状态为阴性,79例患者(均为T3肿瘤)的CRM状态为受累。这些组的中位生存期分别为37个月(范围28-47个月)和18个月(范围13-23个月)(p = 0.0001)。当单独分析T3肿瘤时,T3 CRM受累的肿瘤有比T3 CRM阴性的肿瘤预后更差的趋势(p = 0.074)。根据转移淋巴结受累百分比(<或=或>25%)进行亚分层显示,CRM状态在转移淋巴结负荷低的T3肿瘤中具有更大的预后影响(p = 0.04)。
CRM受累预示着接受手术切除的食管恶性肿瘤患者预后不良,且在我们的研究中是一个独立的预后因素。单独分析T3肿瘤时只有预后更差的趋势。然而,如果CRM为阴性,T3肿瘤且转移淋巴结百分比低的患者预后较好。